Biochrome (C-DAC)

Biochrome (C-DAC)

Biochrome is a high-performance computing (HPC) cluster developed by the Centre for Development of Advanced Computing (C-DAC) in India. It was designed specifically to meet the computational requirements of bioinformatics and life science research, providing advanced facilities for large-scale data analysis, genome sequencing, molecular simulations, and related biological studies.

Background and Development

The emergence of data-driven biology in the early twenty-first century created a significant need for specialised computing infrastructure. With the advent of next-generation sequencing technologies, systems biology, and computational genomics, biological research began generating vast quantities of data that required processing power far beyond what standard computing systems could provide.
Recognising this challenge, C-DAC established the Bioinformatics Resources and Applications Facility (BRAF) to support Indian scientists with state-of-the-art computing tools for bioinformatics. Biochrome was developed under this initiative as a dedicated HPC resource for computational biology. Its purpose was to provide a national platform capable of handling complex data analysis in genomics, proteomics, and molecular modelling, and to strengthen India’s self-reliance in computational research infrastructure.

System Architecture and Features

Biochrome was designed as a blade-server-based HPC cluster optimised for bioinformatics workloads. Its configuration included high-speed processors and a scalable architecture to allow parallel processing of large datasets.
Key technical features include:

  • Peak performance of approximately 5 teraflops, representing the ability to perform five trillion calculations per second.
  • Comprising over 500 processing cores, using high-speed Intel Xeon processors.
  • A high-throughput interconnect network enabling efficient data transfer between nodes.
  • Integration with large-scale data storage systems for handling genomic and molecular datasets.
  • Linux-based operating environment with pre-installed bioinformatics tools and libraries.

The system’s architecture allowed simultaneous execution of multiple computational tasks, making it particularly suitable for sequence analysis, protein structure prediction, and large-scale biological simulations.

Research Applications

Biochrome has been employed across various branches of bioinformatics and life sciences, enabling researchers to carry out computationally demanding studies. Some of its primary applications include:

  • Genome sequencing and assembly: Biochrome supports de novo genome assembly, comparative genomics, and gene annotation, helping researchers analyse complex DNA data from diverse organisms.
  • Cancer and medical genomics: The system has been used in computational oncology research, particularly for identifying genetic mutations, analysing expression data, and modelling cancer pathways.
  • Molecular simulations: It facilitates simulation studies of proteins, enzymes, and other biomolecules to understand their structure–function relationships.
  • Systems biology: The cluster supports the modelling of metabolic and signalling networks, contributing to research in cellular dynamics and bio-regulatory mechanisms.
  • Bioinformatics tool deployment: Biochrome hosts a range of bioinformatics software and databases accessible to the scientific community through C-DAC’s BRAF platform.

Significance and Impact

Biochrome represents an important milestone in India’s efforts to build computational infrastructure for life science research. By providing high-performance computing capacity to academic and research institutions, it helped bridge the gap between biological data generation and computational analysis.
Its impact can be summarised as follows:

  • Scientific empowerment: It provided Indian researchers with access to supercomputing resources for high-level genomic and molecular research.
  • National collaboration: Biochrome enabled cross-institutional collaboration between universities, research laboratories, and medical institutes.
  • Self-reliance: The project reflected India’s growing capability in designing and deploying indigenous HPC systems for specialised domains.
  • Applied research: The facility contributed to translational research areas such as drug discovery, personalised medicine, and disease diagnostics.

Limitations and Challenges

Although Biochrome was a major technological step forward, its computational power, around 5 teraflops, was modest compared with newer petascale and exascale systems developed globally in the subsequent decade. As the volume and complexity of biological data continue to grow, the need for higher-capacity, faster, and more energy-efficient systems has become evident.
Other challenges include:

  • Scalability: Increasing dataset sizes require regular hardware upgrades and software optimisation.
  • Data management: Handling and archiving terabytes of sequencing data demand advanced storage solutions and backup systems.
  • User training: Efficient use of HPC resources depends on user awareness, training, and technical support for researchers.

Legacy and Future Outlook

Biochrome laid the foundation for future bioinformatics-focused supercomputing systems in India. It was part of C-DAC’s broader high-performance computing ecosystem, which includes advanced systems such as PARAM Yuva II and PARAM Siddhi-AI, both of which extend C-DAC’s capabilities into the petascale computing era.
As the global life science community moves toward multi-omics integration, artificial intelligence, and precision medicine, the importance of dedicated computing clusters like Biochrome continues to grow. The future trajectory of such systems is expected to include:

  • Integration with AI-driven analysis platforms for predictive modelling.
  • Use of cloud-enabled HPC frameworks to improve accessibility for researchers.
  • Development of energy-efficient architectures to support sustainable computing.
  • Expansion of bioinformatics software suites and data-sharing facilities.
Originally written on September 28, 2012 and last modified on October 30, 2025.

Leave a Reply

Your email address will not be published. Required fields are marked *